Keros Therapeutics, Inc. · NASDAQ:KROS

The Vanguard Group reported a 6.32% stake in Keros Therapeutics, Inc. (Schedule 13G)

Event Mar 31, 2025 · Filed Apr 30, 2025

The Vanguard Group reported a 6.32% stake in Keros Therapeutics, Inc., 2,566,321 shares, as a passive investor on Mar 31, 2025. Filed Apr 30, 2025 (Schedule 13G).

Stake
6.32%
Shares
2,566,321
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
The Vanguard Group6.32%2,566,321

Source

View original at SEC

Related